Opera Bioscience enables Biotech partners to produce high purity proteins and antibodies for therapeutic use, while also minimizing development and manufacturing timelines. By harnessing a bacterial system that can fully secrete proteins out of the cell in a single step, Opera Bioscience can ensure the creation of high-purity proteins from the outset. This approach removes the need for costly and time-consuming downstream processing steps, capitalizing instead on highly efficient continuous fermentation processes. The outcome is a protein manufacturing solution that is both cost-effective and scalable, allowing customers to expedite the launch of their biosimilars and therapeutics while keeping production costs at a minimum.